News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
454,582 Results
Type
Article (32659)
Company Profile (183)
Press Release (421740)
Section
Business (140878)
Career Advice (1628)
Deals (24001)
Drug Delivery (105)
Drug Development (52486)
Employer Resources (167)
FDA (9616)
Job Trends (12140)
News (232980)
Policy (22327)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (5)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (2139)
Academic (2)
Accelerated approval (1)
Adcomms (23)
Allergies (52)
Alliances (35740)
ALS (63)
Alzheimer's disease (973)
Antibody-drug conjugate (ADC) (84)
Approvals (9609)
Artificial intelligence (194)
Autoimmune disease (8)
Automation (9)
Bankruptcy (224)
Best Places to Work (9431)
BIOSECURE Act (16)
Biosimilars (83)
Biotechnology (94)
Bladder cancer (34)
Brain cancer (22)
Breast cancer (147)
Cancer (1144)
Cardiovascular disease (103)
Career advice (1396)
Career pathing (31)
CAR-T (98)
Cell therapy (256)
Cervical cancer (9)
Clinical research (42292)
Collaboration (568)
Compensation (171)
Complete response letters (24)
COVID-19 (1682)
CRISPR (30)
C-suite (162)
Cystic fibrosis (67)
Data (1043)
Decentralized trials (1)
Denatured (30)
Depression (28)
Diabetes (146)
Diagnostics (4183)
Digital health (5)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (88)
Drug pricing (88)
Drug shortages (18)
Duchenne muscular dystrophy (48)
Earnings (48922)
Editorial (26)
Employer branding (23)
Employer resources (142)
Events (69805)
Executive appointments (531)
FDA (10316)
Featured Employer (41)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (483)
Gene editing (66)
Generative AI (20)
Gene therapy (193)
GLP-1 (539)
Government (3155)
Grass and pollen (2)
Guidances (33)
Healthcare (12270)
Huntington's disease (15)
IgA nephropathy (15)
Immunology and inflammation (56)
Indications (15)
Infectious disease (1768)
Inflammatory bowel disease (104)
Inflation Reduction Act (9)
Influenza (28)
Intellectual property (49)
Interviews (276)
IPO (10510)
IRA (37)
Job creations (3063)
Job search strategy (1203)
Kidney cancer (6)
Labor market (27)
Layoffs (359)
Leadership (12)
Legal (5089)
Liver cancer (42)
Lung cancer (169)
Lymphoma (84)
Machine learning (2)
Management (51)
Manufacturing (206)
MASH (37)
Medical device (6506)
Medtech (6511)
Mergers & acquisitions (13773)
Metabolic disorders (418)
Multiple sclerosis (46)
NASH (20)
Neurodegenerative disease (52)
Neuropsychiatric disorders (15)
Neuroscience (1302)
NextGen: Class of 2025 (4976)
Non-profit (3855)
Northern California (1356)
Now hiring (34)
Obesity (237)
Opinion (197)
Ovarian cancer (42)
Pain (67)
Pancreatic cancer (31)
Parkinson's disease (82)
Partnered (12)
Patents (118)
Patient recruitment (46)
Peanut (29)
People (46492)
Pharmaceutical (79)
Pharmacy benefit managers (12)
Phase I (12051)
Phase II (18200)
Phase III (15239)
Pipeline (526)
Podcasts (69)
Policy (89)
Postmarket research (1780)
Preclinical (5419)
Press Release (65)
Prostate cancer (54)
Psychedelics (25)
Radiopharmaceuticals (173)
Rare diseases (255)
Real estate (4665)
Recruiting (66)
Regulatory (15367)
Reports (48)
Research institute (1896)
Resumes & cover letters (230)
RNA editing (1)
RSV (29)
Schizophrenia (48)
Series A (86)
Series B (51)
Service/supplier (9)
Sickle cell disease (44)
Southern California (1160)
Special edition (13)
Sponsored (25)
Startups (2878)
State (2)
Stomach cancer (9)
Supply chain (43)
The Weekly (38)
United States (12492)
Vaccines (350)
Venture capitalists (31)
Webinars (12)
Weight loss (169)
Women's health (21)
Worklife (14)
Date
Today (102)
Last 7 days (488)
Last 30 days (1974)
Last 365 days (23259)
2025 (3909)
2024 (24052)
2023 (27880)
2022 (35874)
2021 (38379)
2020 (38556)
2019 (36858)
2018 (24011)
2017 (21201)
2016 (20702)
2015 (23848)
2014 (18879)
2013 (15939)
2012 (17163)
2011 (17832)
2010 (16514)
Location
Africa (616)
Alabama (39)
Alaska (6)
Arizona (118)
Arkansas (8)
Asia (28997)
Australia (4308)
California (3084)
Canada (1210)
China (306)
Colorado (151)
Connecticut (138)
Delaware (85)
Europe (62523)
Florida (476)
Georgia (101)
Hawaii (1)
Idaho (36)
Illinois (362)
India (18)
Indiana (240)
Iowa (5)
Japan (106)
Kansas (73)
Kentucky (20)
Louisiana (5)
Maine (22)
Maryland (596)
Massachusetts (2370)
Michigan (117)
Minnesota (207)
Mississippi (1)
Missouri (53)
Montana (25)
Nebraska (18)
Nevada (24)
New Hampshire (35)
New Jersey (1004)
New Mexico (28)
New York (967)
North Carolina (637)
North Dakota (8)
Northern California (1356)
Ohio (115)
Oklahoma (10)
Oregon (30)
Pennsylvania (659)
Puerto Rico (6)
Rhode Island (17)
South America (883)
South Carolina (7)
South Dakota (1)
Southern California (1160)
Tennessee (52)
Texas (420)
Utah (100)
Virginia (111)
Washington D.C. (51)
Washington State (222)
West Virginia (2)
Wisconsin (42)
454,582 Results for "dow pharmaceutical sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index
December 23, 2024
·
4 min read
BioForest
Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year
Gilead Sciences, Inc. announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index for the third consecutive year.
December 11, 2023
·
3 min read
Pharm Country
Regeneron Named on Dow Jones Sustainability World Index for Fifth Consecutive Year
Regeneron Pharmaceuticals, Inc. announced its inclusion on the Dow Jones Sustainability World Index for the fifth consecutive year, alongside its fourth consecutive inclusion on the Dow Jones Sustainability North America Index.
December 11, 2023
·
3 min read
Business
Chicago Area’s Life Sciences Scene Continues Making an Impression
While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical Consortium and COUR Pharmaceuticals executives share what makes the area a hot spot.
January 30, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Corvus Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Press Releases
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
February 20, 2025
·
2 min read
Press Releases
Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February
February 5, 2025
·
6 min read
Press Releases
Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 10, 2025
·
1 min read
Press Releases
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
February 27, 2025
·
1 min read
·
Lori Ellis
1 of 45,459
Next
